Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study

Journal

BMC Cancer

Journal Volume

22

Journal Issue

1

Date Issued

2022

Author(s)

Chen S.-C.

Huang Y.-H.

Chen M.-H.

Hung Y.-P.

Lee R.-C.

Chao Y.

DOI

10.1186/s12885-022-09173-4

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122956162&doi=10.1186%2fs12885-022-09173-4&partnerID=40&md5=8b8ec554a2d33d1f72e4cad989a81437

https://scholars.lib.ntu.edu.tw/handle/123456789/623990

Publisher

BioMed Central Ltd

Type

journal article